Developing cellular therapies for retinal degenerative diseases

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 2, 2014, Pages 1191-1201

  Bharti, Kapil ^a   Rao, Mahendra ^b   Hull, Sara Chandros ^c   Stroncek, David ^b   Brooks, Brian P ^b   Feigal, Ellen ^a   van Meurs, Jan C ^d   Huang, Christene A ^e   Miller, Sheldon S ^a,f  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d California Institute for Regenerative Medicine   (United States)

^e ROTTERDAM UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Age related macular degeneration; Cell based therapy; Retinitis pigmentosa; Stem cells

Indexed keywords

TISSUE SCAFFOLD; TYROSINE KINASE RECEPTOR;

ARTICLE; CELL SUSPENSION; CELL THERAPY; CELLULAR IMMUNITY; CORNEA TRANSPLANTATION; CYTOTOXIC T LYMPHOCYTE; EMBRYONIC STEM CELL; FETAL STEM CELL; GOOD MANUFACTURING PRACTICE; HUMAN; IMMUNOGENICITY; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NATURAL KILLER T CELL; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RETINA DEGENERATION; STEM CELL TRANSPLANTATION; VITREORETINOPATHY;

AGE-RELATED MACULAR DEGENERATION; CELL-BASED THERAPY; RETINITIS PIGMENTOSA; STEM CELLS;

ANIMALS; CELL ENGINEERING; CELL- AND TISSUE-BASED THERAPY; CLINICAL TRIALS AS TOPIC; CONGRESSES AS TOPIC; COOPERATIVE BEHAVIOR; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; HUMANS; NATIONAL EYE INSTITUTE (U.S.); PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE; RETINAL DEGENERATION; STEM CELL TRANSPLANTATION; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84897602264     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13481     Document Type: Article

References (57)

1. Buchholz DE, et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem cells. 2009; 27: 2427-2434.
2. Carr AJ, et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One. 2009; 4: e8152.
3. Klimanskaya I, et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells. 2004; 6: 217-245.
4. Meyer JS, et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2009; 106: 16698-16703.
5. Osakada F, Ikeda H, Sasai Y, Takahashi M. Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc. 2009; 4: 811-824.
6. Osakada F, et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci. 2009; 122 (pt 17): 3169-3179.
7. Ramsden CM, et al. Stem cells in retinal regeneration: past, present and future. Development. 2013; 140: 2576-2585.
8. Reh TA, Lamba D, Gust J. Directing human embryonic stem cells to a retinal fate. Methods Mol Biol. 2010; 636: 139-153.
9. Salero E, et al. Adult human RPE can be activated into a multipotent stem cell that produces mesenchymal derivatives. Cell Stem Cell. 2012; 10: 88-95.
10. Schwartz SD, et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet. 2012; 379: 713-720.
11. Vugler A, et al. Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol. 2008; 214: 347-361.
12. Aftab U, et al. Growth kinetics and transplantation of human retinal progenitor cells. Exp Eye Res. 2009; 89: 301-310.
13. Inoue Y, et al. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res. 2007; 85: 234-241.
14. Lu B, et al. Human adult bone marrow-derived somatic cells rescue vision in a rodent model of retinal degeneration. Exp Eye Res. 2010; 91: 449-455.
15. Lund RD, et al. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells. 2007; 25: 602-611.
16. McGill TJ, et al. Transplantation of human central nervous system stem cells-neuroprotection in retinal degeneration. Eur J Neurosci. 2012; 35: 468-477.
17. Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina. 2011; 31: 1207-1214.
18. Wang S, et al. Non-invasive stem cell therapy in a rat model for retinal degeneration and vascular pathology. PLoS One. 2010; 5: e9200.
19. Kenagy JW, Christensen CM. Disruptive innovation: a new diagnosis for health care's "financial flu. " Healthc Financ Manage. 2002; 56: 62-66.
20. Rao M. Public private partnerships: a marriage of necessity. Cell Stem Cell. 2013; 12: 149-151.
21. Trounson A, DeWitt ND, Feigal EG. The Alpha Stem Cell Clinic: a model for evaluating and delivering stem cell-based therapies. Stem Cells Transl Med. 2012; 1: 9-14.
22. Li R, Maminishkis A, Banzon T. et al. IFN{gamma} regulates retinal pigment epithelial fluid transport. Am J Physiol Cell Physiol. 2009; 297: C1452-C1465.
23. Bahadur G, Morrison M, Machin L. Beyond the 'embryo question': human embryonic stem cell ethics in the context of biomaterial donation in the UK. Reprod Biomed Online. 2010; 21: 868-874.
24. Streiffer R. Informed consent and federal funding for stem cell research. Hastings Cent Rep. 2008; 38: 40-47.
25. Aalto-Setala K, Conklin BR, Lo B. Obtaining consent for future research with induced pluripotent cells: opportunities and challenges. PLoS Biol. 2009; 7: e42.
26. Isasi R, Knoppers BM, Lomax G. Sustained interaction: the new normal for stem cell repositories? Regen Med. 2011; 6783-792.
27. Lowenthal J, Lipnick S, Rao M, Hull SC. Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent. Stem Cells Transl Med. 2012; 1: 409-421.
28. Vatakis DN, et al. Using the BLT humanized mouse as a stem cell based gene therapy tumor model. J Vis Exp. 2012: e4181.
29. Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL. Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol. 2012; 12: 786-798.
30. Brehm MA, Jouvet N, Greiner DL, Shultz LD. Humanized mice for the study of infectious diseases. Curr Opin Immunol. 2013; 25: 428-435.
31. Strauss O, Stumpff F, Mergler S, Wienrich M, Wiederholt M. The Royal College of Surgeons rat: an animal model for inherited retinal degeneration with a still unknown genetic defect. Acta Anatomica. 1998; 162: 101-111.
32. D'Cruz PM, et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet. 2000; 9: 645-651.
33. Navarro-Alvarez N, Yang YG. CD47: a new player in phagocytosis and xenograft rejection. Cell Mol Immunol. 2011; 8: 285-288.
34. van Zeeburg EJ, Maaijwee KJ, Missotten TO, Heimann H, van Meurs JC. A free retinal pigment epithelium-choroid graft in patients with exudative age-related macular degeneration: results up to 7 years. Am J Ophthalmol. 2012; 153: 120-127. e122.
35. van Meurs JC, et al. Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol. 2004; 88110-113.
36. MacLaren RE, Aylward GW. Delayed atrophy of the retinal pigment epithelium after submacular surgery. Euro J Ophthalmol. 2005; 15: 170-172.
37. MacLaren RE, Bird AC, Sathia PJ, Aylward GW. Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration. Ophthalmology. 2005; 112: 2081-2087.
38. van Zeeburg EJ, Cereda MG, van der Schoot J, Pertile G, van Meurs JC. Early perfusion of a free RPE-choroid graft in patients with exudative macular degeneration can be imaged with spectral domain-OCT. Invest Ophthalmol Vis Sci. 2011; 52: 5881-5886.
39. Loewendorf A, Csete M. Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies. Stem Cells Transl Med. 2013; 2: 136-142.
40. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol. 2013; 31: 227-258.
41. Kaplan HJ, Streilein JW. Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte-induced immune deviation. J Immunol. 1978; 120: 689-693.
42. Kaplan HJ, Streilein JW. Immune response to immunization via the anterior chamber of the eye. I. F. lymphocyte-induced immune deviation. J Immunol. 1977; 118: 809-814.
43. Stein-Streilein J. Mechanisms of immune privilege in the posterior eye. Int Rev Immunol. 2013; 32: 42-56.
44. Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol. 2008; 8: 327-336.
45. Prasad D, et al. TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci. 2006; 33: 96-108.
46. Bharti K, Miller SS, Arnheiter H. The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res. 2011; 24: 21-34.
47. Li R, Wen R, Banzon T, Maminishkis A, Miller SS. CNTF mediates neurotrophic factor secretion and fluid absorption in human retinal pigment epithelium. PLoS One. 2011; 6: e23148.
48. Lee JY, Lee DH, Lee JY, Yoon YH. Correlation between subfoveal choroidal thickness and the severity or progression of nonexudative age-related macular degeneration. Invest Ophthalmol Vis Sci. 2013; 54: 7812-7818.
49. Querques L, Querques G, Forte R, Souied EH. Microperimetric correlations of autofluorescence and optical coherence tomography imaging in dry age-related macular degeneration. Am J Ophthalmol. 2012; 153: 1110-1115.
50. Thomas L. The Lives Of A Cell; Notes Of A Biology Watcher. New York, NY: Viking Press; 1974.
51. Thomas L. The Fragile Species. Cambridge, MA: Macmillan New Media; 1993.
52. Thomson JA, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145-1147.
53. Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131: 861-872.
54. Yu J, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007; 318: 1917-1920.
55. Fischbach MA, Bluestone JA, Lim WA. Cell-based therapeutics: the next pillar of medicine. Sci Transl Med. 2013; 5: 179ps177.
56. Norman T, Edwards A, Bountra C, Friend S. The precompetitive space: time to move the yardsticks. Sci Transl Med. 2011; 3: 76cm10.
57. Norman TC, Bountra C, Edwards AM, Yamamoto KR, Friend SH. Leveraging crowdsourcing to facilitate the discovery of new medicines. Sci Transl Med. 2011; 3: 88mr81.